| Ticker Details |
|
Invivyd, Inc.
|
| IPO Date: |
August 6, 2022 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$239.37M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.09 | 5.83%
|
| Avg Daily Range (30 D): |
$0.07 | 5.22%
|
| Avg Daily Range (90 D): |
$0.07 | 4.61%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.56M |
| Avg Daily Volume (30 D): |
3.3M |
| Avg Daily Volume (90 D): |
2.79M |
| Trade Size |
| Avg Trade Size (Sh.): |
333 |
| Avg Trade Size (Sh.) (30 D): |
282 |
| Avg Trade Size (Sh.) (90 D): |
279 |
| Institutional Trades |
| Total Institutional Trades: |
108 |
| Avg Institutional Trade: |
$2.28M |
| Avg Institutional Trade (30 D): |
$.8M |
| Avg Institutional Trade (90 D): |
$1.68M |
| Avg Institutional Trade Volume: |
1.15M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.05M |
| Avg Closing Trade (30 D): |
$.56M |
| Avg Closing Trade (90 D): |
$1.04M |
| Avg Closing Volume: |
1.82M |
|
|
| Financials |
| |
TTM |
Q1 2026 |
Q4 2025 |
|
Basic EPS
|
$-.31
|
$-.13
|
$
|
|
Diluted EPS
|
$-.31
|
$-.13
|
$
|
|
Revenue
|
$55.87M
|
$13.74M
|
$17.21M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-77.6M
|
$-41.4M
|
$-11.07M
|
|
Operating Income / Loss
|
$-81.77M
|
$-43.14M
|
$-12.56M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$136.07M
|
$-42.54M
|
$141.72M
|
|
PE Ratio
|
|
|
|
|
|
|